Browse Category

Financial Insights News 11 November 2025 - 16 December 2025

USA Rare Earth (USAR) Stock News Today: Round Top Timeline Acceleration, Russell 2000 Catalyst, and Analyst Forecasts (Dec. 12, 2025)

USA Rare Earth (USAR) Stock News Today: Round Top Timeline Acceleration, Russell 2000 Catalyst, and Analyst Forecasts (Dec. 12, 2025)

USA Rare Earth, Inc. (NASDAQ: USAR ) is back in focus on Friday, December 12, 2025 , after a fast-moving week that combined company-specific catalysts (a pulled-forward production timeline at its Round Top project), upcoming index inclusion (Russell 2000/3000), and
Transformers & Rectifiers (India) Stock (TARIL): Why the Share Price Jumped on Dec. 12, 2025 — Latest News, Forecasts, and Analyst Outlook

Transformers & Rectifiers (India) Stock (TARIL): Why the Share Price Jumped on Dec. 12, 2025 — Latest News, Forecasts, and Analyst Outlook

Dec. 12, 2025 — Transformers & Rectifiers (India) Ltd (NSE: TARIL, BSE: 532928) snapped a bruising downtrend on Friday, staging a sharp rebound with heavy volumes after sliding to a fresh 52-week low a session earlier. Moneycontrol The move wasn’t
Iren (IREN) Stock on December 2, 2025: Microsoft’s $9.7B AI Deal, $2B Notes Offering and 2026 Price Targets Explained

Iren (IREN) Stock on December 2, 2025: Microsoft’s $9.7B AI Deal, $2B Notes Offering and 2026 Price Targets Explained

Date: December 2, 2025Language: English | Ticker: IREN (Nasdaq) IREN stock is under pressure after a fresh $2 billion convertible notes and equity offering, even as a $9.7 billion Microsoft AI cloud deal, explosive earnings and bullish Wall Street price
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after
Go toTop